Home › Funds › Invenomic Capital Management LP › CNMD
Invenomic Capital Management LP position in CNMD
CONMED CORP · Health Care
Invenomic Capital Management LP reported holding 842,162 shares of CNMD (CONMED CORP) in its Q2 2026 13F filing — a position valued at US$27.6M, representing 1.65% of its reported portfolio and ranking #19 among its reported holdings. Invenomic Capital Management LP has disclosed CNMD holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Invenomic Capital Management LP's CNMD position evolved
Invenomic Capital Management LP first disclosed a stake in CNMD in Q3 2025 at 420,003 shares (US$19.8M). The position peaked in Q1 2026 at 934,601 shares, worth US$33.0M. Across 4 filings, Invenomic Capital Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 842,162 shares valued at US$27.6M — a reduction of -92,439 shares quarter over quarter.. Notable position changes include a 76% increase in Q4 2025 (shares fell 13% over the following quarter), a 27% increase in Q1 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 420.00K | $19.75M | New |
| Q4 2025 | 737.55K | $29.94M | Add |
| Q1 2026 | 934.60K | $33.05M | Add |
| Q2 2026 | 842.16K | $27.56M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNMD and 13F data
CNMD (CONMED CORP) is a Health Care company. 13 other funds we track also report a position in CNMD — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$52.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNMD
- OAKTREE CAPITAL MANAGEMENT LP 53.65M sh · $52.46M · Q2 2026
More on Invenomic Capital Management LP
FAQ
How long has Invenomic Capital Management LP held CNMD?
Invenomic Capital Management LP has disclosed CNMD holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Invenomic Capital Management LP's current position in CNMD?
As of Q2 2026, Invenomic Capital Management LP holds 842.16K shares of CNMD (CONMED CORP), valued at $27.56M, representing 1.65% of its reported portfolio and ranking #19.
Has Invenomic Capital Management LP been buying or selling CNMD?
In the latest 13F filing (Q2 2026), Invenomic Capital Management LP reduced its position in CNMD. The position peaked in Q1 2026 at 934.60K shares.
Which other funds hold CNMD?
Other major institutional holders of CNMD include OAKTREE CAPITAL MANAGEMENT LP, among 13 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.